Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Methotrexate Microemulsion and Phototherapy for Psoriasis
NCT04971239Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of methotrexate in plaque psoriasis (3 arms), sponsored by Assiut University. Primary endpoint: Psoriasis Severity Index at 3 months. Status: unknown.
02
Drugs
methotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04971239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04971239.